Bleiberg H, Rozencweig M, Longeval E, Fruhling J, de Maertelaer V
Surg Gynecol Obstet. 1977 Dec;145(6):821-5.
Liver function tests, liver scintigraphy and peritoneoscopy were carried out in 240 patients with carcinoma. Hepatic invasion was demonstrated by peritoneoscopy essentially when both of the other tests were positive. However, in one-third of the patients, peritoneoscopy revealed the presence of other pathologic changes which could account for the positivity of either of the other diagnostic procedures. The status of the liver, with regard to presence or absence of metastases, could be microscopically documented in 59 patients. False-negative findings of liver chemistry tests, liver scan and peritoneoscopy were seen in 27, 42 and 36 per cent, respectively, of the patients while the rate of false-positive results was 15, 10 and 3 per cent, respectively. The rate of false-negative peritoneoscopy examinations in the absence of simultaneous positivey of the two other investigations was insignificant. These data indicate that liver chemistry tests, liver scan and peritoneoscopy play a major and complementary role in the screening of patients with carcinoma.
对240例癌症患者进行了肝功能检查、肝脏闪烁扫描和腹腔镜检查。基本上当其他两项检查均为阳性时,腹腔镜检查可显示肝侵犯。然而,在三分之一的患者中,腹腔镜检查发现存在其他病理变化,这可能是其他诊断程序之一呈阳性的原因。在59例患者中,可以通过显微镜记录肝脏有无转移的情况。肝功能检查、肝脏扫描和腹腔镜检查的假阴性结果分别见于27%、42%和36%的患者,而假阳性率分别为15%、10%和3%。在其他两项检查不同时呈阳性的情况下,腹腔镜检查的假阴性率微不足道。这些数据表明,肝功能检查、肝脏扫描和腹腔镜检查在癌症患者筛查中起主要的互补作用。